3D printing webinar and virtual event summary: February 28, 2021
3D printing news bulletin, February 27, 2021: Zortrax, Fictiv, Bluestreak I Bright AM, nTopology and KW Micro Power
EOS and Siemens partner in 3D printing software integration and sales
Additive manufacturing industry verticals (automotive, aerospace, consumer, dental, energy, industrial, medical, oil and gas, service bureau)
January 26, 2021
Metal alloy additive manufacturing service area (steel, titanium, copper, aluminum)
Metal additive manufacturing hardware services
Dental Additive Manufacturing in 2021
December 7, 2020
Report number SMP-AM-DENTAL-1220
3D printing in glasses: from mass customization to smart glasses 2021
November 12, 2020
Report number SMP-AM-3DPEYE-1120
Metal Additive Manufacturing Service Market: 2021-2029
November 2, 2020
Report number SMP-AM-MSB-1120
3D printing metal: analysis of patent situation in 2019
July 22, 2019
Report number SMP-MP-0719
3D printing polymers: analysis of the patent landscape – 2016
August 14, 2016
Report number SMP-PATENT-3DPP-0816
3D Printing Metal: Patent Situation Analysis – 2016
March 14, 2016
Report number SMP-PR-3DPM-0316
Metal powder additive manufacturing in 2020
August 18, 2020
Report number SMP-AM-MP-0820
Copper Additive Manufacturing in 2020-Market Database and Outlook
May 7, 2020
Report number SMP-AMC-0520
Market Analysis of Additive Manufacturing Applications: Metal Additive Manufacturing Parts Production
November 24, 2019
Report number SMP-AM-AMA-1119
Manager’s Guide for Implementing Metal Additive Manufacturing in the Production Process
June 26, 2019
Report number SMP-MG-MAM-0619
A guide for additive manufacturing managers in the oil and gas industry
June 13, 2019
Report number SMP-MG-OG-0619
Manager's Guide for Compact Industrial Metal 3D Printers
June 04, 2019
Report number SMP-MG-CMP
A deep collection of selected industries and products.
Videos, podcasts, product reviews and free download resources.
table of Contents
Powerful product database and business catalog search.
February 22, 2021
February 16, 2021
January 28, 2021
August 6, 2020
July 30, 2020
Dig deeper and search our message board 3dprintboard.com
Channel Sales Manager
Post your position here
July 30, 2020
Bioprinting is not only a revolution, it is revolutionizing the way we create and use model systems to answer basic biological questions. it is
-Instead of using systems that rely on small molecules or monotherapy to treat symptoms,
Inherent in stem cells and 3D human tissue-like microenvironment
Bioprinting technology has automatic processing, processing and technical scalability, and has made the latest progress in creating 3D cancer and microenvironment models, and the results in the testing and development of new drugs have been improved.
In this small webinar, learn about the following from frontline speakers in cancer research and bioprinting applications:
4D bioprinting is an additive manufacturing process in which cells, biopolymers and growth factors are combined to form a living structure that mimics natural human tissue. Because of these
. Technology Brings
And it is widely used in the fields of bioengineering and medicine, from the application of new product screening in vitro, disease modeling and animal substitution experiment methods to the application of tissue transplantation and regeneration in vivo.
4D bioprinting technology is mainly composed of three parts: biomaterials, bioprinters and design.
The process mainly includes five key steps:
Bioprinting is not only a revolution, it is working on the way we create and use model systems to answer basic biological questions. This is also a revolution in the way we practice medicine. Instead of using conventional systems that rely on the use of small molecules or biological agents to treat symptoms, the focus of bioprinting transfer is to use the inherent healing potential of stem cells. It enables
By using a bioprinted "niche" (niche) to perfuse the body's stem cells, the niche is composed of growth factors, biomaterials and three-dimensional structures.
In an aging world, the ability to create organizations on demand and provide novel methods of regenerative medicine is critical to improving the quality of life.
ROKIT Healthcare (ROKIT) is a global healthcare company that is the first to use its proprietary 4D bioprinting technology to provide the safest and most effective autologous organ regeneration platform for all types of age-related diseases.
ROKIT's patented technology is the result of the integration of expertise in the fields of autogenous regenerative therapy, biomedical engineering and healthcare chain innovation. The DFU skin and cartilage regeneration platform has been certified by the European Medical Agency (EMA) as non-ATMP, thus shortening the time to market and clinical use. ROKIT has completed the US FDA registration for key components of its organ regeneration platform technology (including the 4D bioprinting system called Dr. INVIVO®).
Korea 4D Bioprinting Technology Open School Activities
Harvard Medical School, Boston, USA
Dearborn University, Michigan
AAPS 2019 U.S. PharmSci 360 Technical Challenge
Korea ROKIT Healthcare Partner Day Event
University of Technology Sydney, Australia
Politecnico di Torino
Autonomous University of Bucaramanga, Colombia
Dr. INVIVO is a 4D bioprinting platform produced by ROKIT Healthcare. To introduce some
Currently, the product portfolio of Dr. INVIVO mainly includes Dr. INVIVO 4D2 and Dr. INVIVO 4D6. The product portfolio is constantly expanding to provide applications and tools for specific organizations or specific purposes.
4D bioprinting is widely used in the fields of bioengineering and medicine. It has in vitro applications in new product screening, disease modeling and alternative methods of animal experiments. It has in vivo applications in tissue transplantation and regeneration. For example, ROKIT Healthcare users use 4D bioprinting to develop:
Case study overview
ROKIT Healthcare collaborates with hospitals and research institutions around the world to transform bioprinting technology from the workbench to the bedside, thereby changing the lives of patients through regenerative therapy for chronic aging-related diseases. It is worth noting that the clinical autologous solution provided by ROKIT for diabetic foot ulcer (DFU) using bioprinted skin patches has been verified by global clinical studies for its safety and effectiveness. The product portfolio of cutting-edge organ regeneration platform technology is continuing to expand to cartilage and kidney regeneration.
Diabetic foot ulcer skin regeneration
Cartilage and kidney regeneration
ROKIT Healthcare is committed to tailoring the best quality tools and services for specific purpose applications of interdisciplinary 4D bioprinting.
ROKIT Healthcare offers the following tools as some examples of the growing product portfolio:
3D cell culture
(Dr. INVIVO BioPoly)
(Dr. INVIVO Pharm)
Find the latest ROKIT articles from the 3DPrint.com team.
Automation, healthcare, metal additive manufacturing (AM) and bioprinting are the four major themes discussed at the 2021 Additive Manufacturing Strategy (AMS) Summit. The two-day virtual event gathered experts to participate in group discussions...
After years of research methods, the treatment of diabetic foot ulcer (DFU), a Korean 3D bioprinter manufacturer, has been managed, and Rokit Healthcare has finally announced the success of a new DFU regeneration platform based on DFU.
ROKIT Healthcare announced the launch of INVIVO 4D6, a bioreactor-based bioprinting platform with a built-in cell incubator and low-temperature plasma sterilizer. it…
Become part of ROKIT Healthcare's journey to revolutionize research and medicine in a new era of organ regeneration. You can keep up to date with ROKIT Healthcare’s latest events, webinars, conference attendance and R&D progress through the following community pages.
all rights reserved.
Register to view and download SmarTech and 3DPrint.com proprietary industry data
Already have an account?